We did not observe any difference in fecal lipocalin-2 levels between groups (Supplementary Fig. 8c), however, we further linked the reduced tumor burden to decreased Th17 cells in vivo (Supplementary Fig. 8d). The gene discussed is LCN2; the disease is neoplasm.